Related references
Note: Only part of the references are listed.
Editorial Material
Oncology
A New Era in Systemic Therapy for Hepatocellular Carcinoma: Atezolizumab plus Bevacizumab Combination Therapy
Masatoshi Kudo
LIVER CANCER (2020)
Editorial Material
Oncology
Limited Impact of Anti-PD-1/PD-L1 Monotherapy for Hepatocellular Carcinoma
Masatoshi Kudo
LIVER CANCER (2020)
Article
Multidisciplinary Sciences
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Share Paper
